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The mitochondrial protein MAVS (also known as
IPS-1, VISA, and CARDIF) interacts with RIG-I-like
receptors (RLRs) to induce type I interferon (IFN-I).
NLRX1 is a mitochondrial nucleotide-binding,
leucine-rich repeats (NLR)-containing protein that
attenuates MAVS-RLR signaling. Using Nlrx1/
cells, we confirmed that NLRX1 attenuated IFN-I
production, but additionally promoted autophagy
during viral infection. This dual function of NLRX1
paralleled the previously described functions of the
autophagy-related proteins Atg5-Atg12, but NLRX1
did not associate with Atg5-Atg12. High-throughput
quantitative mass spectrometry and endogenous
protein-protein interaction revealed an NLRX1-
interacting partner, mitochondrial Tu translation
elongation factor (TUFM). TUFM interacted with
Atg5-Atg12 and Atg16L1 and has similar functions
as NLRX1 by inhibiting RLR-induced IFN-I but pro-
moting autophagy. In the absence of NLRX1, in-
creased IFN-I and decreased autophagy provide an
advantage for host defense against vesicular stoma-
titis virus. This study establishes a link between an
NLR protein and the viral-induced autophagic
machinery via an intermediary partner, TUFM.
INTRODUCTION
The mitochondrion is a coordinating site for several key host
responses against viral infection including apoptosis and type IIFN (IFN-I) signaling (Brenner and Mak, 2009; Lei et al., 2009;
Rehwinkel and Reis e Sousa, 2010). Upon infection with a RNA
virus, virus-related RNA species are recognized by retinoic-
acid inducible gene I (RIG-I)-like receptors (RLRs), including
RIG-I and MDA5 (melanoma differentiation associated gene 5)
(Rehwinkel and Reis e Sousa, 2010). The 50-ppp moiety of cyto-
solic dsRNA is the molecular signature that activates RIG-I
(Hornung et al., 2006; Myong et al., 2009), and RIG-I deficiency
leads to compromised IFN-I in response to vesicular stomatitis
virus (VSV), Sendai virus (SeV), and Newcastle disease virus
(NDV) (Kato et al., 2006). The helicase domain drives the
unwinding of dsRNA with 30 terminal overhang via its ATPase
activity (Takahasi et al., 2008). Upon activation, RIG-I binds to
its adaptor, the mitochondrial antiviral signaling protein (MAVS,
also referred to as IPS-1, VISA, or Cardif) via homotypic CARD
interaction to activate IFN-I by facilitating the nuclear transloca-
tion of the transcription factors NF-kB and IRF3 (Kawai et al.,
2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005).
Similar to MAVS, another adaptor protein STING (also referred
to as MITA, ERIS, or MPYS) is ubiquitously expressed and is
indispensable for inducing IFN-I upon RIG-I activation (Ishikawa
and Barber, 2008; Ishikawa et al., 2009; Sun et al., 2009; Zhong
et al., 2008; Zhong et al., 2009). Overexpression of STING is less
potent than MAVS in the activation of IRF3 (Zhong et al., 2008),
and it may employ a separate mechanism via its association
with components of the endoplasmic reticulum translocon-
associated protein (TRAP) complex to modulate RLR signaling
(Ishikawa and Barber, 2008).
Because of the potential detrimental effects of IFN-I,
several molecular machineries keep the RLR pathway in check.
A unique member of the nucleotide-binding domain (NBD)
and leucine-rich-repeats (LRRs)-containing proteins (NLRs),
NLRX1, resides in the mitochondria and attenuates the activa-
tion ofMAVS by binding to its CARDdomain, possibly precludingImmunity 36, 933–946, June 29, 2012 ª2012 Elsevier Inc. 933
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was first discovered by bioinformatic data mining based on the
sequence of CIITA (Harton et al., 2002). NLRs have diverse bio-
logical functions including formation of the caspase-1-activating
inflammasome protein complex, modulation of host antipatho-
gen response, regulation of gene transcription, and cytokine,
chemokine, and defensin production (Ting et al., 2010).
Emerging evidence suggests that NLRs actively participate in
antiviral signaling pathways. Among these, NLRX1 was the first
NLR found to negatively impact IFN-I production (Allen et al.,
2011; Moore et al., 2008). In addition to NLR-based complexes,
the autophagy-related protein conjugate, Atg5-Atg12, has also
been shown to regulate the RLR signaling pathway. The absence
of autophagy, which causes the degradation of misfolded pro-
teins and cytoplasmic organelles to recycle nutrients (Sanjuan
and Green, 2008; Virgin and Levine, 2009), results in significantly
higher RLR signaling, leading to more IFN-I production in mouse
embryonic fibroblasts (MEFs) (Jounai et al., 2007; Ke and Chen,
2011; Tal et al., 2009). One study showed that Atg5-deficient
cells and Atg7-deficient cells, in which the Atg5-Atg12 con-
jugation is impeded, exhibit enhanced IFN-I response to virus
(Jounai et al., 2007). Another report showed that the absence
of autophagy leads to amplification of the RLR pathway by
causing the elevation of MAVS and by elevating reactive oxygen
species (ROS), which increases RLR (Tal et al., 2009). However,
the role of autophagy in RLR signaling appears to be cell
type specific given that such inhibitory effects were not seen in
plasmacytoid dendritic cells (Lee et al., 2007). Nonetheless, the
relationship between the two regulatory functions of RLR in
IFN-I and autophagic signaling remains to be studied and how
NLRs might integrate these two pathways has not been
addressed.
This study employs quantitative proteomics approaches and
uncovered a regulatory mitochondrial protein complex com-
prised of NLRX1 and the mitochondrial Tu translation elongation
factor (TUFM). This complex regulates virus-induced IFN-I
activation and autophagy by engaging RIG-I and the autoph-
agy-related proteins Atg5-Atg12 conjugate and Atg16L1. This
shows that a complex comprised of NLRX1, TUFM, RIG-I, and
Atg5-Atg12 and Atg16L1 controls two crucial antiviral functions:
IFN-I induction and autophagy.
RESULTS
NLRX1 Inhibits IFN-I Signaling in MEFs
Previously we showed that NLRX1 attenuates IFN-I production
(Allen et al., 2011). However, the MEFs were generated from
different litters. To confirm the role of NLRX1 in modulating
IFN-I signaling, we generated littermate-controlled MEFs with
or without theNlrx1 gene by intercrossing heterozygous Nlrx1+/
mice tominimize genetic differences between theMEFs.WT and
Nlrx1/MEFs were cultured from 13.5 day embryos; the lack of
Nlrx1 transcripts in Nlrx1/ MEFs was confirmed by RT-PCR
(Figure S1A available online). When MEFs from both genotypes
were challenged with VSV, a deficiency in NLRX1 resulted in
enhanced cytokines production including IL-6, TNF-a, and
IFN-I both in transcript levels (Figure S1B) and protein levels (Fig-
ure S1C). These findings confirmed recent studies from our
group (Allen et al., 2011; Moore et al., 2008). Another group934 Immunity 36, 933–946, June 29, 2012 ª2012 Elsevier Inc.also showed that NLRX1 negatively regulates inflammatory cyto-
kine production in response to viral infection or Toll-like receptor
activation (Xia et al., 2011).
TUFM Associates with NLRX1
We previously found that NLRX1 interacts with MAVS to impede
the latter’s interaction with RIG-I at a basal state, thus suggest-
ing that NLRX1 might form an active inhibitory complex at the
unstimulated state (Allen et al., 2011; Moore et al., 2008). To
further explore this possibility, we employed size exclusion chro-
matography and found that NLRX1 is most abundant in a higher
molecular mass during the resting state, whereas it resides in
smaller molecular complexes upon RLR activation by the RLR
ligand, 50ppp-dsRNA (Figure 1A, upper panels). As an internal
control, the mitochondrial protein cytochrome c oxidase (COX)
IV-containing complex did not display an altered size profile in
response to 50-ppp dsRNA challenge (Figure 1A, lower panels).
To identify additional molecules that might interact with
NLRX1 and participate in NLRX1-mediated immune effects, we
employed the amino acid-coded mass tagging (AACT, also
known as SILAC)-assisted quantitative mass spectrometry to
identify NLRX1-interacting proteins (Chen et al., 2000; Zhu
et al., 2002) (Figure 1A). The N-terminal domains of NLRs are
considered to mediate protein-protein interaction, whereas
LRRs are considered inhibitory (Moore et al., 2008; Ye and
Ting, 2008). Hence, we constructed vectors encoding full-length
NLRX1 and a mutant lacking the LRR domain and used these as
baits to identify interacting partners. Eluted proteins from both
groups (eluates I and II) (Figure 1B) were separately fractionated
by SDS-PAGE (Figure 1C) followed by high-performance liquid
chromatography and mass spectrometry. A subcellular com-
partment localization analysis of the NLRX1 interactome re-
vealed that a high percentage of interacting partners are mito-
chondrial proteins (Figure S1D). Among these, peptide profiles
that matched the mitochondrial Tu translation elongation factor
(TUFM) with ion scores of >39 were identified in both eluates
(Figures S1E-1H). This indicates with >95% certainty that these
peptides represent TUFM (Table S1).
To further validate these findings, we performed recip-
rocal coimmunoprecipitation experiments to show interaction
between ectopically expressed NLRX1 and TUFM (Figure 1D).
Most importantly, endogenous TUFM coimmunoprecipitated
with endogenous NLRX1 (Figure 1E). This interaction appears
to be specific, given that TUFM did not coimmunoprecipitate
with multiple mitochondrial proteins with various submito-
chondrial locations, including Bcl-xL (mitochondrial outer mem-
brane), apoptosis-inducing factor (AIF, mitochondrial inter-
membrane space), COX IV (mitochondrial inner membrane),
and voltage-dependent anion channel (VDAC, mitochondrial
outer membrane) (Figure 1E). NLRX1-TUFM interaction requires
the N terminus of NLRX1 given that its deletion (NLRX1-DX)
abolished this interaction (Figure 1F). Deletion of the LRR domain
(NLRX1-DLRR) slightly increased this interaction, whereas con-
structs expressing NBD or LRR alone (NLRX1-NBD, NLRX1-
LRR) did not interact with TUFM. As negative controls, NLRX1
did not bind to the cytoplasmic homolog of TUFM, eEF1a1 (Fig-
ure 1F). Furthermore, TUFM did not coprecipitate with other
NLRs such as NLRP12 and CIITA when compared to an empty
vector (EV) control (Figure 1G).
Figure 1. TUFM Interacts with NLRX1
(A) Five million HEK293T cells were transfected with 50ppp-dsRNA or control dsRNA; cells were harvested and homogenized in hypotonic lysis buffer 16 hr after
transfection. Total cell protein extractions were then separated by size exclusion chromatography, and collected fractions were subjected to immunoblotting
against NLRX1 and COX IV. One of three independent experiments is shown.
(B) Scheme of AACT/SILAC mass spectrometry identification of NLRX1-interacting partners.
(C) Immunoprecipitated proteins were eluted by HA-peptide and separated by SDS-PAGE; the gel was continuously sliced as indicated for further ultra-high
performance liquid chromatography and mass spectrometry analyses.
(D) HA-tagged NLRX1 was cotransfected with either empty vector or FLAG-tagged TUFM. Cells were lysed and immunoprecipitated proteins were blotted for
either FLAG-TUFM or HA-NLRX1 as indicated.
(E) HEK293T cells were lysed and immunoprecipitated with either isotype control antibody or anti-TUFM and blotted for NLRX1, TUFM, Bcl-xL, AIF, COX IV,
and VDAC.
(F) Full-length NLRX1 or its truncation mutants were expressed in HEK293T cells, and protein samples were blotted for endogenous TUFM and eEF1a1.
(G) Overexpressed NLRX1, NLRP12, and CIITA were immunoprecipitated from HEK293T cells and blotted for endogenous TUFM. In each of (D)–(G), the results
are representative of two to four independent experiments.
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Figure 2. TUFM Inhibits RIG-I-Mediated Type I IFN Production
(A) The protein sequences of human TUFM (accession number: NP_003312), mitochondrial EF-Tu in A. thaliana (accession number: NP_192202) and EF-Tu in
L. monocytogenes (accession number: YP_002759310).
(B–F) HEK293T cells were transfected with DRIG-I or MITA/STING expression plasmid plus luciferase reporter plasmids for ISRE, NF-kB, or IFNB1 activation.
FLAG-TUFM plasmid was titrated into the system and cells were lysed 24 hr after transfection for luciferase assays.
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NLRX1 and TUFM Promote Virus-Induced AutophagyTUFM Potently Inhibits RIG-I Signaling
Similar to NLRX1 (Moore et al., 2008), TUFM is ubiquitously
expressed in multiple tissue and cell types (Figures S2A and
S2B). NLRX1 is a highly conserved protein; thus we also evalu-
ated the evolutionary conservation of TUFM. TUFM is conserved
from humans to its bacterial counterpart. The bacterial elonga-
tion factor Tu (EF-Tu) serves as a pathogen-associated molec-
ular pattern (PAMP) in plant cells to elicit immune activation
(Kunze et al., 2004; Zipfel et al., 2006). However, despite this
general sequence homology, the key activating sequence of
bacterial EF-Tu KxKFxR no longer exists in the human or
A. thaliana counterparts; instead, the N terminus of TUFM has
undergone drastic changes (Figure 2A).
Given the interaction of NLRX1 with TUFM and previous find-
ings that NLRX1 attenuates MAVS and RIG-I induced IFN-I
production and NF-kB signaling (Allen et al., 2011; Moore et al.,
2008; Xia et al., 2011), we analyzed the role of TUFM in these
same pathways. Similar to NLRX1, TUFM inhibited ISRE- and
NF-kB-dependent and IFNB1 promoter activation by DRIG-I in
a dose-dependent fashion (Figure 2B-D). IFN-I signaling in
response to cytosolic viral PAMPs is also regulated by the
adaptor MITA (STING) (Ishikawa and Barber, 2008; Ishikawa
et al., 2009; Zhong et al., 2008). However, neither TUFM nor
NLRX1 affected ISRE activation by MITA, indicating specificity
of these two proteins in the RIG-I pathway (Figures 2E and 2F).
In addition to reporter assays, TUFM inhibited DRIG-I-induced
IFNB1 mRNA production, similar to NLRX1 (Figure 2G). RNA
interference targeting of TUFM (si-TUFM) partially reduced
TUFM expression (Figure S2C) and increased IFNB1 mRNA
induction by DRIG-I (Figure 2H). Reduction of TUFM expression
also resulted in lower viral plaque forming units (PFUs) compared
to control cells (Figure 2I). As an additional approach for assess-
ing the IFN-I-regulatory function of TUFM, GFP-expressing VSV
was used to infect HEK293T cells stably transduced with a doxy-
cycline-inducible shRNA lentivirus (Figure S2D). In the control
group, doxycycline did not affect the percentage of infected cells
and viral infection as assayed by the GFP-positive population
and mean fluorescence intensity (MFI) (Figure 2J). By contrast,
induction of TUFM shRNA reduced both signals (Figure 2K).
These results indicate that TUFM is similar to NLRX1 in attenu-
ating RLR signaling. Reducing the expression of both NLRX1
and TUFM further resulted in enhanced IFNB1mRNA (Figure 2L).
NLRX1 Is Essential for VSV-Induced Autophagy in MEFs
Another key host response that is elicited by virus is autophagy.
In addition to IFN-I induction, VSV is known to induce autophagy
(Jounai et al., 2007; Shelly et al., 2009) during which the light
chain 3 (LC3) protein is converted from a cytosolic form(G) DRIG-I was cotransfected with either TUFM or NLRX1 into HEK293T cells, a
transfection.
(H) Endogenous TUFM was partially reduced by transfecting a pool of four targ
measured by RT-PCR.
(I) HEK293T cells with reduced TUFM expression and control cells were challenge
(J) HEK293T cells were transduced with control lentiviruses and infected with VSV
for VSV.
(K) HEK293T cells transduced with sh-TUFM were treated and analyzed as desc
(L) HEK293T cells transduced with scrambled control shRNA or sh-NLRX1 were
16 hr after transfection of either empty vector control or DRIG-I plamid. IFN
representative of three independent experiments.(LC3B-I) to a LC3B-lipidated, membrane-associated form
(LC3B-II) and displays a punctate appearance (Kabeya et al.,
2000; Mizushima et al., 2010). To study the role of NLRX1 in
autophagy, we inoculatedWT and Nlrx1/ cells with VSV. Auto-
phagosome formation was measured by LC3B conversion by
immunoblotting, punctate appearance by immunofluorescence
staining, and direct observation of autophagosomes by trans-
mission electron microscopy (TEM) (Klionsky et al., 2008). In
WT MEFs, VSV infection increased LC3B-II level relative to
b-actin (Figure 3A). Two widely used lysosomal protease inhibi-
tors, chloroquine (Figure 3B) and bafilomycin A1 (Figure S3),
did not reverse the reduced amount of LC3B-II in VSV-infected
Nlrx1/ MEFs compared to control MEFs. This suggests that
decreased autophagic activity in Nlrx1/ MEFs was due to
decreased autophagosome synthesis and not an increased
degradation of autophagic substrates. The inclusion of a lower
exposure in Figure 3B is necessary given that chloroquine treat-
ment caused increased and overexposed LC3B signals. VSV
infection promoted the punctated staining of endogenous
LC3B (Figure 3C) and exogenously expressed GFP-LC3B (Fig-
ure 3D) and increased number of double-membrane bound
autophagosomes (Figure 3E), as noted by others (Jounai et al.,
2007; Shelly et al., 2009). All of these were dramatically
decreased in Nlrx1/ MEFs (Figures 3A–3E). Rapamycin, an
inhibitor of the mTOR signaling and an inducer of autophagy,
resulted in a modest reduction in LC3B-II in Nlrx1/ compared
to WT cells (Figure 3A).
Given that NLRX1 is an attenuator of several inflammatory
cytokines, Nlrx1/ MEFs is known to produce increased pro-
inflammatory cytokines such as IFN-I, TNF-a, and IL-6 (Figures
S1B and S1C) (Allen et al., 2011; Xia et al., 2011). To determine
whether the defective VSV-induced autophagy observed in
Nlrx1/ MEFs is caused by a reduced level of IFN-I, we tested
MEFs with a deficiency in IFN-a receptor (Ifnar/), a common
receptor for IFN-I. WT and Ifnar1/ MEFs showed a similarly
increase in LC3B-II amounts upon VSV infection, indicating
that VSV-induced autophagy is independent of IFN-I signaling
(Figure 3F). We also tested the possibility that difference in the
amounts of multiple cytokines controlled by NLRX1 may cause
defective autophagy in Nlrx1/ MEFs. To address this, we
cultured WT and Nlrx1/ MEFs respectively in the upper and
lower chamber (Figure 3G, left panel), or vice versa (Figure 3G,
right panel), in a transwell system where the culture milieu is
shared. VSV-infected Nlrx1/ MEFs still exhibited a greatly
decreased LC3B-II level relative to b-actin compared to WT
MEFs in both setups (Figure 3G). Therefore, defective autophagy
in Nlrx1/ MEFs is not due to extrinsic alterations in soluble
mediators, but rather due to a cell-intrinsic mechanism.nd cells from all groups were harvested for real time PCR analysis 24 hr after
eting siRNA into the cells; DRIG-I was transfected to induce IFNB1 mRNA as
d with VSV, and plaque assay was performed for assessment of the viral titers.
-GFP (MOI of 0.1) for 16 hr and analyzed by flow cytometry for GFP as amarker
ribed in (I).
treated with control or siRNA pool targeting TUFM. Cells were then harvested
B1 mRNA abundance was analyzed by RT-PCR. Results of all panels are
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Figure 3. NLRX1 Is Essential for VSV-Induced Autophagy in MEFs
(A) WT and Nlrx1/ MEFs were infected with VSV for 12 hr or treated with rapamycin for 2 hr. Protein samples were immunoblotted for LC3B. Densitometry
analysis to quantify ratio of LC3B-II to b-actin is shown at the bottom.
(B) WT andNlrx1/MEFs were infected with VSV (MOI of 0.1) for 12 hr in the absence or presence chloroquine (20 mM). Immunoblotting for LC3Bwas performed
and densitometry analysis as described in (A) is shown at the bottom.
(C) WT and Nlrx1/MEFs were infected with VSV (MOI of 0.1), fixed and stained for endogenous LC3B 12 hr after infection, and examined by confocal imaging.
Quantitation of autophagosomes was performed by counting LC3B puncta in 50 cells (C, bottom).
(D) WT and Nlrx1/ MEFs were transduced with LC3B-GFP expression vector for 24 hr and then infected with VSV (MOI of 0.1) for 12 hr. Cells were fixed and
examined by confocal imaging. Quantitation of autophagosomes was performed by counting LC3B puncta in 20 cells (D, bottom).
(E) WT and Nlrx1/MEFs were infected with VSV (MOI of 0.1) for 12 hr and examined by transmission electron microscopy for autophagosomes. Quantitation is
based on counting the number of autophagosomes in ten cells per treatment (E, bottom).
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NLRX1 and TUFM Promote Virus-Induced AutophagyNLRX1 Affects Virus-Induced Autophagy in Peritoneal
Macrophages
We next explored the role of NLRX1 in autophagy in a pri-
mary immune cell type, peritoneal macrophages. Similar to
MEFs, VSV-infected Nlrx1/ peritoneal macrophages showed
decreased autophagy markers when compared to similarly
treated WT controls. These observations include decreased
LC3B-II: b-actin ratio in the presence or absence of chroloquine
(Figure 4A), decreased endogenous LC3B punctate staining
(Figure 4B), and less autophagosomes (Figure 4C).
To extend these findings to human cells, we produced len-
tiviral vector harboring shRNA targeting human NLRX1 and its
controls. HEK293T cells with sh-NLRX1 construct showed
reduced endogenous NLRX1 expression and reduced LC3B-II:
b-actin ratio compared to controls in the presence or absence
or chloroquine (Figures 5A and 5B). The association of the
Atg5-Atg12 conjugate with MAVS has been shown to inhibit
MAVS-mediated IFN-I production (Jounai et al., 2007). Thus,
we explored the interaction of Atg5-Atg12 with NLRX1, but did
not detect an association under stringent lysis and wash condi-
tions (Figure 5C). This led us to hypothesize that an additional
protein exists to engage both IFN-I and autophagy pathways
and we explored whether TUFM is such an intermediary.
TUFM Associates with Atg5-Atg12 Conjugate
To test the hypothesis that TUFM engages with both NLRX1 and
Atg5-Atg12 conjugate, we performed a hemi-endogenous coim-
munoprecipitation analysis. This revealed strong interaction of
Atg5-Atg12 with TUFM but not with NLRX1, MITA, or CIITA
(Figure 6A). As a positive control, MAVS also interacted with
Atg5-Atg12 as reported (Jounai et al., 2007). TUFM and MAVS
also associate with Atg16L1, an essential autophagy partner of
Atg5-Atg12 (Levine et al., 2011).
A previous study has shown that Atg5-Atg12 can be
transiently localized to the mitochondria (Hailey et al., 2010). If
so, a model can be evoked where MAVS, NLRX1, TUFM, and
Atg5-Atg12 association takes place within the mitochondria.
To assess this, we prepared mitochondria-enriched fractions
by using the described protocol (Figure S4). In these fractions,
we detected NLRX1, TUFM, MAVS, and Atg5-Atg12 conjugate,
but not the ER protein calreticulin or the ER marker detected
by anti-KDEL (Figure 6B). As positive controls, these fractions
were enriched for mitochondrial COX IV and Bcl-xL. We further
tested whether LC3B is recruited to the mitochondria after VSV
infection. Ectopically overexpressed LC3B shows punctate
appearance after VSV infection, but does not colocalize with
the mitochondria identified by MitoTracker staining, suggesting
that autophagy of mitochondria (mitophagy) was not occurring
under these test conditions (Figure 6C), although further analysis
is needed to address this issue fully.
To map the essential domains for the Atg5-Atg12 conjugate
recruitment, we generated TUFM truncation mutants (Fig-
ure 6D). The N-terminal domain I of TUFM was required for(F) WT and Ifnar/ MEFs were infected with VSV (MOI of 0.1) for 12 hr. Protein s
(A) is shown at the bottom.
(G) WT and Nlrx1/ MEFs were respectively placed in the upper and lower cham
were infected with VSV for 12 hr. Protein samples were immunoblotted for LC3B. D
representative of three independent experiments. Values in (C)–(E) are expresseoptimal interaction with Atg5-Atg12, whereas domains II and III
were not as critical (Figure 6E). To explore the physiological
significance of such interaction, we utilized the TUFM stable
knockdown cells described above to investigate whether TUFM
also affects autophagy. Lentiviral vector-transduced HEK293T
cells were challenged with VSV, which induced LC3B-II for-
mation. However, cells with sh-TUFM displayed significantly
reduced LC3B-II (Figure 6F). This indicates that TUFM, similar
to NLRX1, also regulates viral-induced autophagy.
Autophagy and IFN-I Cooperatively Regulate VSV
Replication
Thus far, we have demonstrated that NLRX1 and TUFM regu-
lated autophagy and IFN-I production during VSV infection. An
important question is the biological effects of IFN-I and autoph-
agy on virus replication in mammalian cells. Although the
antiviral effect of IFN-I has been well established, the role of
autophagy in viral replication is less established. Both pro-
and antiviral effects of autophagy have been proposed depend-
ing on the virus and host cells. For example, dengue virus use
autophagy to obtain essential nutrients and macromolecules
to support its replication (Heaton and Randall, 2010), whereas
coxsackievirus B3 requires autophagy for optimal infection
and pathogenesis (Alirezaei et al., 2012). Other studies show
that autophagy enhances viral clearance (Orvedahl et al.,
2010; Shelly et al., 2009). Therefore, we sought to determine
whether autophagy promotes or inhibits VSV replication.
3-Methyladenine (3-MA), a widely used autophagy inhibitor of
class III phosphoinositide 3-kinase (PI3K), moderately but signif-
icantly decreased VSV mRNA expression (Figure 7A, left panel)
and VSV particles in the supernatant (Figure 7A, right panel),
suggesting that VSV might utilize the host autophagy pathway
to facilitate its replication in mammalian cells. Furthermore,
macrophages with deficiency in autophagy molecule Atg5
(Atg5/) show similarly decreased VSV mRNA expression (Fig-
ure 7B, left panel) and VSV particles in the supernatant (Fig-
ure 7B, right panel) that are statistically significant. Reduced
virus replication observed in 3-MA-treated cells or Atg5/ cells
are in agreement with the observation that Nlrx1/ cells, which
have defective autophagy, showed a dramatic repression of
virus replication (Figure 7C). However, defective autophagy
could not fully explain VSV replication defect in Nlrx1/ cells,
given that VSV mRNA level and VSV titers in WT MEFs treated
with 3-MA were still significantly higher than those in Nlrx1/
cells (Figure 7D). On the basis of the higher production of IFN-I
by viral-infected Nlrx1/ cells (Figures S1B and S1C; Allen
et al., 2011), we hypothesized that defective autophagy and
enhanced IFN-I might act cooperatively to inhibit VSV replication
in Nlrx1/ cells. To this end, we used the combination of
3-MA treatment and the addition of recombinant mouse IFN-b
(600 pg/ml) to WT MEF at a similar level as that produced by
VSV-infected Nlrx1/ MEF (Figure S1C) to decrease VSV
titer to the level observed in Nlrx1/ MEFs (Figure 7E). Thisamples were immunoblotted for LC3B. Densitometry analysis as described in
ber (left panel) or vice versa (right panel) in the transwell culture system. Cells
ensitometry analysis as described in (A) is shown at the bottom. The results are
d as mean ± SD. *p < 0.05, versus controls.
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Figure 4. NLRX1 Is Essential for VSV-Induced Autophagy in Peritoneal Macrophages
(A) Naive peritoneal macrophages were isolated from WT or Nlrx1/ (KO, knockout) mice and infected with VSV for 12 hr in the presence or absence of
chloroquine (20 mM). Protein samples were immunoblotted for LC3B. Densitometry analysis for quantifying the ratio of LC3B-II to b-actin was shown at the right.
(B and C) Naive peritoneal macrophages isolated from WT or Nlrx1/ mice were infected with VSV (MOI of 0.1) for 12 hr. Cells were fixed and stained for
endogenous LC3B (B, left). Quantitation of autophagosomes was performed by counting LC3B puncta in 50 cells (B, right). Cells were fixed and examined by
transmission electron microscopy for autophagosomes (C, left). Quantitation is based on counting the number of autophagosomes in ten cells per treatment
(C, right). The results are representative of two independent experiments. Values in (B) and (C) are expressed as mean ± SD. *p < 0.05, versus controls.
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NLRX1 and TUFM Promote Virus-Induced Autophagyexperiment suggests that both reduced autophagy and
enhanced IFN-I can lead to better control of VSV replication.
DISCUSSION
Our previous analysis showed that NLRX1 is a negative regulator
of the MAVS-RIG-I induced IFN-I response (Allen et al., 2011;
Moore et al., 2008). In the current study, we showed that
NLRX1 dually regulated IFN-I and autophagy through the940 Immunity 36, 933–946, June 29, 2012 ª2012 Elsevier Inc.engagement of a mitochondrial protein, TUFM. TUFM associ-
ated with NLRX1 and the Atg5-Atg12 conjugate, serving as
an intermediary between NLRX1 and Atg5-Atg12. Similar to
NLRX1, TUFM inhibited NF-kB- and ISRE-dependent and
IFNB1 promoter activities in a dose-dependent manner, and
the overexpression of TUFM suppressed IFNB1 mRNA tran-
scription. Reduction of both NLRX1 and TUFM resulted in
enhanced IFN-I activation, thus demonstrating a partnership
between NLRX1 and TUFM to control host antiviral responses.
Figure 5. NLRX1 Is Essential for VSV-
Induced Autophagy in Human Cells
(A) HEK293T cells were transfected with control
lentiviral sh-EV, sh-scrambled, or sh-NLRX1 (left).
Cells were infected with VSV (MOI of 0.1) and
harvested 12 hr after infection for LC3B immuno-
blotting (middle). Densitometry analysis to quantify
ratio of LC3B-II to b-actin is shown at the right.
(B) HEK293T cells transfected with sh-EV, sh-
scrambled, or sh-NLRX1 were infected with VSV
(MOI of 0.1) in the absence or presence of chlo-
roquine (20 mM). Cells were harvested 12 hr after
infection for LC3B immunoblotting. Densitometry
analysis as described in (A) is shown at the bottom.
(C) FLAG-tagged NLRX1 or MAVS and HA-tagged
Atg5 and Atg12 expression plasmids were trans-
fected into HEK293T cells. Cell extracts were
harvested 24 hr after transfection and subjected to
coimmunoprecipitation as indicated. Results of all
experiments are representative of at least two to
three repeats.
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NLRX1 and TUFM Promote Virus-Induced AutophagyPrevious work has shown the association of multiple check-
point proteins with MAVS, because MAVS is found to be in
a supramolecular complex in the quiescent state, migrates
into a lower molecular weight complex when cells are activated
(Yasukawa et al., 2009). This suggests that during viral activa-
tion, MAVS is released from these molecular brakes, presum-
ably so that it can engage the RLR proteins that are themselves
activated by the binding of viral RNAs. This report confirms that
NLRX1 resides in a larger molecular complex in the quiescent
state but is in a smaller molecular mass in response to cytosolic
50ppp-dsRNA treatment. This led us to identify TUFM as an
NLRX1-interacting partner. Functional analysis of NLRX1 and
TUFM indicates that they phenocopy each other. Thus, TUFM
also serves to attenuate RIG-I-dependent IFN-I production
and promotes viral-induced autophagy. Autophagy has been
increasingly appreciated as a central mechanism for modu-
lating host innate antiviral responses. Several proteins are
found to dually control IFN-I and autophagy. For example, the
Atg5-Atg12 conjugate are found to regulate the RLR signaling
pathway and negatively impact IFN-I activation (Jounai et al.,
2007; Tal et al., 2009). In MEFs, the absence of Atg5 results
in enhanced IFN-I partially because of the accumulation of
intracellular ROS due to a deficiency of autophagy (Tal et al.,
2009). Additionally, the Atg5-Atg12 conjugate has been shown
to intercalate between RIG-I and MAVS, abolishing RLR-
induced IFN-I gene activation (Jounai et al., 2007). Another
protein that has been found to dually regulate autophagy and
IFN-I is Mfn2. Mfn2 is a mitochondrial outer membrane GTPase
and regulates mitochondrial fusion together with its close
homolog Mfn1 (Chan, 2006). Recent evidence suggests that
Mfn2 is needed for autophagosome formation (Hailey et al.,
2010), whereas Mfn2/ cells exhibit enhanced IFN-I produc-
tion (Yasukawa et al., 2009). Interestingly, Mfn2 also interactsImmunity 36, 933–9with MAVS to preclude its association
with RLR, providing a plausible mecha-
nism for how it interferes with the RLR-
MAVS signaling complex (Yasukawa
et al., 2009). Thus, the downregulationof IFN-I and induction of autophagy appear to be mediated
by a group of proteins with dual functions, including NLRX1
and TUFM described here. It is noteworthy that whereas
a previous study of VSV in Drosophila showed that autophagy
is an antiviral host response (Shelly et al., 2009), this study
shows that autophagy enhances viral transcript and titer. This
is probably attributed to species or cell type differences. Their
paper used the Drosophila melanogaster Schneider 2 cell line
(which has features of a macrophage-like lineage) and hemo-
cytes for their in vitro work, whereas our functional studies
were performed in fibroblasts. In fact, autophagy has been
implicated in facilitating the replication of several viruses,
such as Encephalomyocarditis virus and Chikungunya virus,
in mammalian fibroblastic cell lines (Krejbich-Trotot et al.,
2011; Zhang et al., 2011).
Although the immune function of TUFM has not been demon-
strated before, its bacterial homolog EF-Tu is found across the
bacterial kingdom and is known to function as a PAMP in plants
(Kunze et al., 2004; Zipfel et al., 2006). The immune-eliciting
activity of EF-Tu resides in its N-terminal 12 amino acids (Kunze
et al., 2004). It is possible that bacterial EF-Tu is incorporated
into host cells and gradually evolves to become TUFM, while
its function evolved from immune-activation to immune-
suppression. A comparison of EF-Tu and TUFM shows that the
N-terminal immune-activating sequence of EF-Tu is lacking in
TUFM, and a mitochondria-targeting sequence is found in the
mammalian homolog. In addition to immune modulation, TUFM
has also been implicated in protein translation elongation and
biosynthesis, oncogenesis, oxidative phosphorylation, and pro-
tein quality control (Bhargava et al., 2004; Suzuki et al., 2007;
Valente et al., 2007; Wells et al., 1995). More investigations are
necessary to elucidate whether the diverse functions of TUFM
are interrelated.46, June 29, 2012 ª2012 Elsevier Inc. 941
Figure 6. TUFM Associates with the Atg5-Atg12 Conjugate
(A) HEK293T cells were transfected with empty vector or FLAG-tagged NLRX1, TUFM, MAVS, MITA/STING, or CIITA. Cell lysates were immunoprecipitated with
anti-FLAG M2 affinity gel and then blotted for Atg5 or Atg16L1. The immunoblot of Atg5 represents the Atg5-Atg12 conjugate form.
(B) Crude mitochondria were isolated from cells untreated or infected with VSV with the protocol described in Figure S4. All samples were subjected to SDS-
PAGE and immunoblotting.
(C) HEK293T cells were transfected with LC3B-GFP expression vector. After VSV infection (MOI of 0.1) for 12 hr, cells were fixed and stained with MitoTracker
Deep Red.
(D) Domain structures of TUFM and truncation mutants.
(E) FLAG-tagged TUFM wild-type and domain truncation mutants were cotransfected with HA-Atg5 and HA-Atg12 into HEK293T cells. Cell extracts were
immunoprecipitated with anti-FLAG and immunoblotted for the HA-Atg5-Atg12 conjugate.
(F) HEK293T cells transduced with tetracycline-inducible shRNA for TUFM and/or control shRNA were infected with VSV (MOI of 0.1) and harvested for LC3B
immunoblotting. Results of all experiments are representative of at least two to three repeats.
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NLRX1 and TUFM Promote Virus-Induced AutophagyIn summary, previous studies have shown a central role
for Atg5-Atg12 in autophagy induction and IFN-I inhibition.
This work identifies a mitochondrial protein interaction be-
tween NLRX1 and TUFM that coordinately controls IFN-I
and autophagy through association of the latter with Atg5-942 Immunity 36, 933–946, June 29, 2012 ª2012 Elsevier Inc.Atg12 and Atg16L1. By recruiting Atg5-Atg12 and NLRX1,
TUFM serves as a nodal checkpoint of the RIG-I-MAVS
axis. These data expand our understanding of the players in-
volved in controlling diverse mitochondria-based antiviral
responses.
Figure 7. NLRX1-Mediated IFN-I Inhibition and Autophagy Enhancement Cooperatively Promotes Virus Replication
(A) WT MEFs were infected with VSV (MOI of 0.1) for 12 or 24 hr in the absence or presence of autophagy inhibitor, 3-methyladenine (3-MA, 10 mM). VSV
replication was determined by measuring VSV transcripts by RT-PCR (A, left) or virus titer by standard plaque assay (A, right).
(B) WT and Atg5/ bone marrow-derived macrophages were infected with VSV with indicated dosage for 24 hr. VSV replication was determined as described
in (A).
(C) WT and Nlrx1/ MEFs were infected with VSV (MOI of 0.1) for 12 or 24 hr. VSV replication was determined as described in (A).
(D) WT and Nlrx1/MEFs were infected with VSV (MOI of 0.1) for 24 hr in the absence or presence of 3-MA. VSV replication was determined as described in (A).
(E) WT and Nlrx1/ MEFs were treated as indicated. Exogenous IFN-b (600 pg/ml) is determined by the difference in IFN-b produced by WT versus Nlrx1/
MEFs in Figure S1C. Values are expressed as mean ± SD. *p < 0.05, versus controls.
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Cell Culture
Nlrx1/ MEFs and their littermate WT controls were made from 13.5 day
embryos and maintained in complete DMEM medium. Cells transduced with
tetracycline-inducible shRNA delivery lenti-viruses were cultured in DMEM
complete medium containing 10% tet system-approved FBS (Cat. 631105,
Clontech). All cells were grown in 37C incubator supplied with 5% CO2.Experimental Animals
Nlrx1/ C57BL/6 mice have been described previously (Allen et al., 2011).
Mice with the floxed Atg5 locus (Hara et al., 2006) were crossed with Cre-
recombinase transgenic mice under the control of the Lysosomal-M promoter.
All experimental mice were bred in a pathogen-free facility at the University of
North Carolina at Chapel Hill in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and the Institutional
Animal Care.Immunity 36, 933–946, June 29, 2012 ª2012 Elsevier Inc. 943
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FLAG-tagged TUFM expression plasmid was a kind gift from N. Takeuchi at
the University of Tokyo, Japan. FLAG-tagged MITA expression plasmid
and ISRE reporter plasmid were generously provided by H. Shu at Wuhan
University, China. The domain truncation mutants of TUFM were generated
in accordance with standard molecular cloning protocols. LC3B-GFP ex-
pression vector was purchased from Addgene.
RT-PCR and Gene Tissue Expression
RT-PCR was performed as previously described (Allen et al., 2011). The
expression data of TUFM in multiple cell and tissue types was made available
by the BioGPS project (http://biogps.gnf.org/), funded by the Genomics
Institute of the Novartis Research Foundation.
RNAi-Based Protein Expression Knockdown
NLRX1mRNAwas targeted with a lentiviral delivery system to stably introduce
shRNA expressed from a pol III promoter. The promoter, targeting shRNA or
scrambled shRNA hairpin sequence, and polyT termination signal were ampli-
fied by PCR from a U6 promoter template and cloned into the lentiviral vector
FG12. To generate the tetracycline-inducible lentiviral shRNA delivery system
targeting TUFM, we obtained Expression Arrest non-silencing TripZ con-
trol bacteria stock (Cat. RHS4743, Thermo Scientific Open Biosystems)
and TUFM-targeting shRNA-containing construct bacteria stock (Oligo ID
V2THS_222080, Cat. RHS4696-99362407, Thermo Scientific Open Biosys-
tems). The ON-TARGETplus SMARTpool of four siRNA targeting TUFM (Cat.
L-016741-01-0005, Thermo Scientific) and the control pool of four siRNA
(Cat. D-001810-10-05, Thermo Scientific) were transfected into the cells in
accordance with the manual.
Gel Filtration
A total of 23 107 HEK293T cells were transfected with either control dsRNA or
50-ppp dsRNA (Invivogen). Cells were harvested 16 hr after transfection and
lysed in hypotonic lysis buffer with a Dounce homogenizer. The homogenate
was centrifuged at 500 g for 15 min for nuclei separation. The supernatants
were filtered and loaded onto Superose 6 HR-10/30 columns (GE Healthcare).
Five hundred microliters of each fraction was collected and separated by
SDS-PAGE.
AACT-Based Mass Spectrometry
AACT-based mass spectrometry was performed as previously described
(Chen et al., 2000). In brief, HEK293T cells were transduced with retroviruses
expressing empty vector, HA-tagged NLRX1 full-length, or NLRX1DLRR trun-
cation. Cells with empty vector were grown in DMEM L-Leucine-deficient
medium (Cat. D9816, US Biological) supplemented with L-Leucine-5,5,5-d3
(Cat. 486825, Sigma-Aldrich). NLRX1-expressing or NLRX1DLRR-expressing
cells were cultured in regular medium. Cells were lysed and immunoprecipi-
tated with anti-HA affinity matrix (Cat. 11815016001, Roche). The eluted
fractions were subjected to SDS-PAGE and Coomassie staining. The
Coomassie-stained gel lanes were continuously excised and the peptides
were lyophilized and then resuspended in buffer A (2% acetonitrile, 98%
water, and 0.1% formic acid). LC-MS/MS analysis was performed on a
nanoAcquity UPLC-QTOF API US system (Waters). All the raw files acquired
on QTOF were processed with Mascot Distiller software (version 2.3, Matrix
Science) and then searched against human International Protein Index (IPI)
protein database (version 3.26, 67665 sequences). Only proteins that had
at least two unique peptides achieving an ion score above 39 and contained
at least five consecutive amino acids matching the database peptides
sequences were considered to be positive identifications. All the raw spec-
trum and SILAC ratios were manually evaluated. Gene Ontology annotation
analysis was performed with DAVID Bioinformatics Resources (http://david.
abcc.ncifcrf.gov/).
Transfection and Viral Infection
HEK293T cells were plated so that they could reach80%confluence the next
day for transfections. FuGENE 6 (Cat. 11814443001, Roche) was used for cell
transfection. VSV-GFP virus was propagated in VERO cells (ATCC,Manassas,
VA). Cell lines or primary cells were plated in 24-well plate 24 hr prior to infec-
tion to reach 80% confluence the next day. Virus inoculum was prepared in944 Immunity 36, 933–946, June 29, 2012 ª2012 Elsevier Inc.prewarmed serum-free DMEM and incubated with cells for 1 hr at 37C.
Then the virus inoculum was removed and cells were replenished with
complete media.
Coimmunoprecipitation and Immunoblots
Cells were lysed in RIPA buffer (1% Triton X-100, 0.25% DOC, 0.05% SDS,
50mM Tris-HCl [pH 8.0], 150 mMNaCl, and 50mMNaF) or NP-40-based lysis
buffer (1% NP-40, 50 mM Tris-HCl [pH 8.0], and 150 mM NaCl) containing
complete protease inhibitor cocktail (Cat. 11873580001, Roche). For the
endogenous coimmunoprecipitation experiments, whole cell lysates were pre-
cleared with protein A resin (Cat. L00210, GenScript) and protein G resin (Cat.
L00209, GenScript) for 1 hr at 4C, and then incubated with primary antibody
overnight. The protein A/G UltraLink resin (Cat. 53132, Thermo Scientific) was
added and incubated for 2 hr at 4C. Beads were washed five times before
resuspension and boiling in the Laemmli’s sample buffer. Protein samples
were separated by NuPAGE Bis-Tris 4%–12%precast gels (Cat. NP0322BOX,
Invitrogen) or Tris-Glycine 16% precast gels (Cat. EC64952BOX, Invitrogen).
The antibodies used in this study are as follows: High-affinity anti-HA-
peroxidase (Cat. 12013819001, Roche), Anti-FLAG M2 affinity gel (Cat.
A2220, Sigma-Aldrich), anti-LC3B (Cat. 2775, Cell Signaling), anti-TUFM
(Cat. ab67991, abcam), anti-TUFM (Cat. HPA018991, Sigma-Aldrich), anti-
eEF1a1 (Cat. sc-28578, Santa Cruz), anti-Bcl-xL (Cat. 2762, Cell Signaling),
anti-Atg5 (Cat. 2630, Cell Signaling), anti-calreticulin (Cat. 2891S, Cell
Signaling), anti-Atg16L1 (Cat. 8089, Cell Signaling), and anti-Actin-HRP (Cat.
sc-1615HRP, Santa Cruz).
Luciferase Assay
Assays were performed as previously described (Moore et al., 2008).
Laser Confocal Imaging Analysis
WT or Nlrx1/ MEFs were seeded on eight-well glass slide (Cat. 154534,
Thermo Fisher Scientific) 24 hr prior to treatments. The next day, cells were
incubated with VSV-GFP at the MOI of 0.1 for 1 hr in serum-free DMEM,
and then the virus inoculum was removed. Cells were replenished with
complete medium and incubated for 4 hr. Cells were fixed and permeabilized
with 4% paraformaldehyde containing 0.1% Triton X-100 for 20 min at room
temperature. The cells were washed three times with 1 3 PBS. Samples
were incubated with blocking buffer (7% BSA, 1% FBS, 2% goat serum,
and 1% Fc block) for 1 hr at room temperature. LC3B antibody was diluted
at 1:400 in the blocking buffer. The samples were incubated with primary anti-
body overnight at 4C and then incubated for 4 hr with Alexa Fluor 647 goat
anti-rabbit antibody (Cat. A-21244, Invitrogen) diluted at 1:2000 ratio in the
blocking buffer. Images were acquired with an Olympus FV500 confocal
microscope.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.immuni.2012.03.025.
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